Ambrisentan

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 60505-4553
  • Package NDC 60505-4553-3
  • Application number ANDA210701
  • SPL ID 2950aca0-011d-ea24-bbd4-4557a0fe1aec
  • SPL set ID 291a782a-77e1-8a8e-e1c8-2626f305c2b7
  • UNII HW6NV07QEC
  • RxCUI 722116
  • RxCUI 722122

What the source publishes

Labeler
Apotex Corp.
Active ingredients
AMBRISENTAN
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:60505-4553_2950aca0-011d-ea24-bbd4-4557a0fe1aec
{
  "name": "Ambrisentan",
  "splId": "2950aca0-011d-ea24-bbd4-4557a0fe1aec",
  "labels": [
    {
      "setId": "291a782a-77e1-8a8e-e1c8-2626f305c2b7",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=291a782a-77e1-8a8e-e1c8-2626f305c2b7",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=291a782a-77e1-8a8e-e1c8-2626f305c2b7"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Apotex Corp.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (60505-4553-3)",
      "package_ndc": "60505-4553-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220919"
    }
  ],
  "productId": "60505-4553_2950aca0-011d-ea24-bbd4-4557a0fe1aec",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "60505-4553",
  "deaSchedule": null,
  "genericName": "AMBRISENTAN",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "AMBRISENTAN",
      "strength": "10 mg/1"
    }
  ],
  "applicationNumber": "ANDA210701",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220919",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175581",
      "N0000175364"
    ],
    "upc": [
      "0360505455232",
      "0360505455331"
    ],
    "unii": [
      "HW6NV07QEC"
    ],
    "rxcui": [
      "722116",
      "722122"
    ],
    "spl_set_id": [
      "291a782a-77e1-8a8e-e1c8-2626f305c2b7"
    ],
    "pharm_class_epc": [
      "Endothelin Receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Endothelin Receptor Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Apotex Corp."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:60505-4553_2950aca0-011d-ea24-bbd4-4557a0fe1aec"